Loading…

Modifying the risk: Once-a-day bathing “at risk” patients in the intensive care unit with chlorhexidine gluconate

Chlorhexidine gluconate (CHG) decreases hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) that can cause colonization and infection. A standard approach is the bathing of all patients with CHG to prevent MRSA transmission. To decrease CHG utilization, this study assessed selective...

Full description

Saved in:
Bibliographic Details
Published in:American journal of infection control 2014-05, Vol.42 (5), p.571-573
Main Authors: Armellino, Donna, RN, DNP, CIC, Woltmann, Jeanine, RN, BSN, CIC, Parmentier, Darlene, RN, MSN, MBA, CNML, Musa, Nancy, RN, BSN, Eichorn, Ann, MS, Silverman, Robert, MD, Hirschwerk, David, MD, Farber, Bruce, MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chlorhexidine gluconate (CHG) decreases hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) that can cause colonization and infection. A standard approach is the bathing of all patients with CHG to prevent MRSA transmission. To decrease CHG utilization, this study assessed selective daily administration of CHG bathing to intensive care unit patients who had an MRSA-positive result or a central venous catheter. This risk-based approach was associated with a 72% decrease in hospital-acquired MRSA transmission rate.
ISSN:0196-6553
1527-3296
DOI:10.1016/j.ajic.2013.12.026